Pharmacogenetic Trial of Noradrenergic Medication for Treatment of Cocaine Abuse
Phase of Trial: Phase II
Latest Information Update: 04 Dec 2017
Price : $35 *
At a glance
- Drugs Doxazosin (Primary)
- Indications Cocaine abuse
- Focus Therapeutic Use
- 28 Nov 2017 Status changed from recruiting to completed.
- 19 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
- 28 Mar 2014 Planned initiation date changed from 1 Oct 2013 to 1 Apr 2014 as reported by ClinicalTrials.gov record.